£515.00

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

Price data last checked 150 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 16 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 321 days • 321 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 25 February 2025 16 May 2025 04 August 2025 23 October 2025 11 January 2026

Price Distribution

Price distribution over 321 days • 1 price levels

Days at Price
321 days 0 80 161 241 321 £515 Days at Price

Price Analysis

Most common price: £515 (321 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 321 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
99% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States

£520.00 09 Jan 2026
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
99% match

The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis

£790.00 14 Jan 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan
99% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan

£495.00 05 Jan 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes
98% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes

£490.00 13 Feb 2026
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
98% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 14 Jan 2026
The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City
97% match

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

£995.00 23 Jan 2026
The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City
97% match

The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City

£795.00 06 Apr 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for Digital Therapeutics Sales in India
96% match

The 2023-2028 Outlook for Digital Therapeutics Sales in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for Medical Foods in the United States
96% match

The 2023-2028 Outlook for Medical Foods in the United States

£520.00 24 Jan 2026
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
96% match

Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments

IntechOpen

£114.00 16 Feb 2026
Multiple Sclerosis in Children and Adolescents - Medical Book
96% match

Multiple Sclerosis in Children and Adolescents - Medical Book

£139.75 19 Apr 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in India
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in India

£515.00 22 Jan 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
96% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India

£595.00 29 Jan 2026
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
96% match

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

£325.00 08 Feb 2026
The 2023-2028 Outlook for Medical Imaging Analysis Software in India
96% match

The 2023-2028 Outlook for Medical Imaging Analysis Software in India

£515.00 25 Jan 2026
The 2023-2028 World Outlook for Advanced Therapy Medicinal Products
96% match

The 2023-2028 World Outlook for Advanced Therapy Medicinal Products

£795.00 12 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
96% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Bio-Based Food Ingredients in India
96% match

The 2023-2028 Outlook for Bio-Based Food Ingredients in India

£515.00 01 Feb 2026
The 2023-2028 Outlook for Viral Infections in India
96% match

The 2023-2028 Outlook for Viral Infections in India

£515.00 28 Jan 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
96% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China

£595.00 09 Mar 2026